StockNews.com Initiates Coverage on Pro-Dex (NASDAQ:PDEX)

StockNews.com initiated coverage on shares of Pro-Dex (NASDAQ:PDEX – Free Report) in a research note published on Monday morning. The firm issued a buy rating on the medical instruments supplier’s stock. Pro-Dex Trading Up 1.3 % Shares of PDEX stock opened at $17.33 on Monday. Pro-Dex has a 52-week low of $14.51 and a 52-week […]

Leave a Reply

Your email address will not be published.

Previous post Regulus Therapeutics (NASDAQ:RGLS) Earns Hold Rating from Analysts at StockNews.com
Next post RE/MAX (NYSE:RMAX) Stock Rating Reaffirmed by JPMorgan Chase & Co.